HEADER BLOOD CLOTTING,HYDROLASE/INHIBITOR 19-MAY-05 1ZRB TITLE THROMBIN IN COMPLEX WITH AN AZAFLUORENYL INHIBITOR 23B COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ALPHA-THROMBIN; COMPND 5 SYNONYM: COAGULATION FACTOR II; COMPND 6 EC: 3.4.21.5; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: 11-PEPTIDE HIRUDIN FRAGMENT; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: PANCREAS; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 9 ORGANISM_TAXID: 6421 KEYWDS THROMBIN; THROMBIN INHIBITOR COMPLEX, BLOOD CLOTTING, HYDROLASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.J.STAUFFER,P.D.WILLIAMS,H.G.SELNICK,P.G.NANTERMET,C.L.NEWTON, AUTHOR 2 C.F.HOMNICK,M.M.ZRADA,S.D.LEWIS,B.J.LUCAS,J.A.KRUEGER,B.L.PIETRAK, AUTHOR 3 E.A.LYLE,R.SINGH,C.MILLER-STEIN,R.B.WHITE,B.WONG,A.A.WALLACE, AUTHOR 4 G.R.SITKO,J.J.COOK,M.A.HOLAHAN,M.STRANIERI-MICHENER,Y.M.LEONARD, AUTHOR 5 J.J.LYNCH JR.,D.R.MCMASTERS,Y.YAN REVDAT 4 30-OCT-24 1ZRB 1 REMARK LINK REVDAT 3 13-JUL-11 1ZRB 1 VERSN REVDAT 2 24-FEB-09 1ZRB 1 VERSN REVDAT 1 07-JUN-05 1ZRB 0 JRNL AUTH K.J.STAUFFER,P.D.WILLIAMS,H.G.SELNICK,P.G.NANTERMET, JRNL AUTH 2 C.L.NEWTON,C.F.HOMNICK,M.M.ZRADA,S.D.LEWIS,B.J.LUCAS, JRNL AUTH 3 J.A.KRUEGER,B.L.PIETRAK,E.A.LYLE,R.SINGH,C.MILLER-STEIN, JRNL AUTH 4 R.B.WHITE,B.WONG,A.A.WALLACE,G.R.SITKO,J.J.COOK,M.A.HOLAHAN, JRNL AUTH 5 M.STRANIERI-MICHENER,Y.M.LEONARD,J.J.LYNCH JR., JRNL AUTH 6 D.R.MCMASTERS,Y.YAN JRNL TITL 9-HYDROXYAZAFLUORENES AND THEIR USE IN THROMBIN INHIBITORS JRNL REF J.MED.CHEM. V. 48 2282 2005 JRNL REFN ISSN 0022-2623 JRNL PMID 15801822 JRNL DOI 10.1021/JM049423S REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.0 REMARK 3 NUMBER OF REFLECTIONS : 25664 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1695 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2331 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 169 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.920 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ZRB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAY-05. REMARK 100 THE DEPOSITION ID IS D_1000033028. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31563 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : 0.07500 REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, SODIUM PHOSPHATE, PH 7.3, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 34.69500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.65500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 34.69500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.65500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 14L REMARK 465 GLY A 14M REMARK 465 ARG A 15 REMARK 465 THR A 146A REMARK 465 TRP A 146B REMARK 465 THR A 146C REMARK 465 ALA A 146D REMARK 465 ASN A 146E REMARK 465 VAL A 146F REMARK 465 GLY A 146G REMARK 465 LYS A 146H REMARK 465 GLN B 365 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 14K CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 10 CA - CB - CG ANGL. DEV. = 16.2 DEGREES REMARK 500 GLU A 61 CA - CB - CG ANGL. DEV. = 20.8 DEGREES REMARK 500 ARG A 165 CA - CB - CG ANGL. DEV. = -14.4 DEGREES REMARK 500 ARG A 175 CA - CB - CG ANGL. DEV. = 21.8 DEGREES REMARK 500 LYS A 236 CA - CB - CG ANGL. DEV. = 17.1 DEGREES REMARK 500 GLU B 358 CA - CB - CG ANGL. DEV. = 13.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 7 -87.16 -129.77 REMARK 500 TYR A 60A 82.13 -155.18 REMARK 500 ASN A 60G 69.44 -162.79 REMARK 500 HIS A 71 -60.33 -131.47 REMARK 500 ILE A 79 -60.13 -123.84 REMARK 500 GLU A 97A -68.47 -124.46 REMARK 500 SER A 115 -166.79 -160.67 REMARK 500 PHE A 245 59.60 -111.59 REMARK 500 GLU B 357 -92.60 -43.05 REMARK 500 GLU B 358 126.77 161.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 062 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF 11-PEPTIDE HIRUDIN REMARK 800 FRAGMENT DBREF 1ZRB A 1A 246 UNP P00734 THRB_HUMAN 335 621 DBREF 1ZRB B 355 365 UNP P28504 HIR2_HIRME 55 65 SEQRES 1 A 287 ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SER LEU SEQRES 2 A 287 GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER TYR ILE SEQRES 3 A 287 ASP GLY ARG ILE VAL GLU GLY SER ASP ALA GLU ILE GLY SEQRES 4 A 287 MET SER PRO TRP GLN VAL MET LEU PHE ARG LYS SER PRO SEQRES 5 A 287 GLN GLU LEU LEU CYS GLY ALA SER LEU ILE SER ASP ARG SEQRES 6 A 287 TRP VAL LEU THR ALA ALA HIS CYS LEU LEU TYR PRO PRO SEQRES 7 A 287 TRP ASP LYS ASN PHE THR GLU ASN ASP LEU LEU VAL ARG SEQRES 8 A 287 ILE GLY LYS HIS SER ARG THR ARG TYR GLU ARG ASN ILE SEQRES 9 A 287 GLU LYS ILE SER MET LEU GLU LYS ILE TYR ILE HIS PRO SEQRES 10 A 287 ARG TYR ASN TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA SEQRES 11 A 287 LEU MET LYS LEU LYS LYS PRO VAL ALA PHE SER ASP TYR SEQRES 12 A 287 ILE HIS PRO VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SEQRES 13 A 287 SER LEU LEU GLN ALA GLY TYR LYS GLY ARG VAL THR GLY SEQRES 14 A 287 TRP GLY ASN LEU LYS GLU THR TRP THR ALA ASN VAL GLY SEQRES 15 A 287 LYS GLY GLN PRO SER VAL LEU GLN VAL VAL ASN LEU PRO SEQRES 16 A 287 ILE VAL GLU ARG PRO VAL CYS LYS ASP SER THR ARG ILE SEQRES 17 A 287 ARG ILE THR ASP ASN MET PHE CYS ALA GLY TYR LYS PRO SEQRES 18 A 287 ASP GLU GLY LYS ARG GLY ASP ALA CYS GLU GLY ASP SER SEQRES 19 A 287 GLY GLY PRO PHE VAL MET LYS SER PRO PHE ASN ASN ARG SEQRES 20 A 287 TRP TYR GLN MET GLY ILE VAL SER TRP GLY GLU GLY CYS SEQRES 21 A 287 ASP ARG ASP GLY LYS TYR GLY PHE TYR THR HIS VAL PHE SEQRES 22 A 287 ARG LEU LYS LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE SEQRES 23 A 287 GLY SEQRES 1 B 11 ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU GLN MODRES 1ZRB TYS B 363 TYR O-SULFO-L-TYROSINE HET TYS B 363 16 HET 062 A1001 35 HETNAM TYS O-SULFO-L-TYROSINE HETNAM 062 3-AZA-9-HYDROXY-9-FLUORENYLCARBONYL-L-PROLYL-2- HETNAM 2 062 AMINOMETHYL-5-CHLOROBENZYLAMIDE, N-OXIDE FORMUL 2 TYS C9 H11 N O6 S FORMUL 3 062 C26 H25 CL N4 O4 FORMUL 4 HOH *169(H2 O) HELIX 1 1 PHE A 7 SER A 11 5 5 HELIX 2 2 THR A 14B TYR A 14J 1 9 HELIX 3 3 ALA A 55 CYS A 58 5 4 HELIX 4 4 PRO A 60B ASP A 60E 5 4 HELIX 5 5 THR A 60I ASN A 62 5 3 HELIX 6 6 ASP A 125 LEU A 130D 1 9 HELIX 7 7 GLU A 164 SER A 171 1 8 HELIX 8 8 LYS A 185 GLY A 186C 5 5 HELIX 9 9 LEU A 234 PHE A 245 1 12 SHEET 1 A 7 SER A 20 ASP A 21 0 SHEET 2 A 7 GLN A 156 PRO A 161 -1 O VAL A 157 N SER A 20 SHEET 3 A 7 LYS A 135 GLY A 140 -1 N VAL A 138 O VAL A 158 SHEET 4 A 7 PRO A 198 LYS A 202 -1 O VAL A 200 N ARG A 137 SHEET 5 A 7 TRP A 207 TRP A 215 -1 O TYR A 208 N MET A 201 SHEET 6 A 7 GLY A 226 HIS A 230 -1 O PHE A 227 N TRP A 215 SHEET 7 A 7 MET A 180 ALA A 183 -1 N PHE A 181 O TYR A 228 SHEET 1 B 7 GLN A 30 ARG A 35 0 SHEET 2 B 7 GLU A 39 LEU A 46 -1 O CYS A 42 N LEU A 33 SHEET 3 B 7 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 45 SHEET 4 B 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 B 7 LYS A 81 ILE A 90 -1 N TYR A 89 O LEU A 105 SHEET 6 B 7 LEU A 64 ILE A 68 -1 N VAL A 66 O SER A 83 SHEET 7 B 7 GLN A 30 ARG A 35 -1 N PHE A 34 O LEU A 65 SHEET 1 C 2 LEU A 60 TYR A 60A 0 SHEET 2 C 2 LYS A 60F ASN A 60G-1 O LYS A 60F N TYR A 60A SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.03 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.02 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.04 LINK C GLU B 362 N TYS B 363 1555 1555 1.33 LINK C TYS B 363 N LEU B 364 1555 1555 1.33 CISPEP 1 SER A 36A PRO A 37 0 -0.19 SITE 1 AC1 15 HIS A 57 TYR A 60A TRP A 60D GLU A 97A SITE 2 AC1 15 ASP A 189 ALA A 190 SER A 195 VAL A 213 SITE 3 AC1 15 SER A 214 TRP A 215 GLY A 216 GLY A 219 SITE 4 AC1 15 GLY A 226 PHE A 227 HOH A1088 SITE 1 AC2 15 PHE A 34 GLN A 38 GLU A 39 LEU A 40 SITE 2 AC2 15 LEU A 65 ARG A 73 THR A 74 ARG A 75 SITE 3 AC2 15 TYR A 76 GLU A 80 LYS A 81 ILE A 82 SITE 4 AC2 15 HOH B 67 HOH B 107 HOH B 161 CRYST1 69.390 71.310 72.150 90.00 100.35 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014411 0.000000 0.002632 0.00000 SCALE2 0.000000 0.014023 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014089 0.00000